Laurel A. Menapace/LinkedIn
Aug 2, 2026, 09:04
Laurel A. Menapace: Investing in the Next Generation of Hematology Leaders
Laurel A. Menapace, Former Senior Clinical Research Director of Rare Blood Disorders, Fitusiran Development Program at Sanofi, shared a post on LinkedIn:
“Thoroughly enjoyed participating in ISTH’s ECC Networking with Industry Session.
Some of the best career advice I’ve received has come from people willing to share their experiences openly.
I’m grateful for the opportunity to pay that forward and discuss career paths, clinical development, industry partnerships, and the many ways we can continue advancing therapies for patients.
Building the future of hematology requires more than great science—it requires investing in the people who will lead it.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C